查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426359

2024 年产前与新生儿基因检测全球市场报告

Prenatal And Newborn Genetic Testing Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

产前和新生儿基因检测的市场规模预计在未来几年将快速成长。预计到 2028 年将以 12.5% 的复合年增长率 (CAGR) 增长至 107 亿美元。预测期内的预期增长是由基因检测小组的扩大、孕产妇健康意识的提高、产前和新生儿筛检指南的遵守、对罕见疾病的更多关注以及伦理和监管考虑所推动的。这被认为是由于这个原因。预测期内预期的主要趋势包括非侵入性产前检测（NIPT）的普及、基因序列测定（WGS）和全EXOME序列测定的使用，以及人工智慧（AI）在基因检测过程中的整合。基因检测实践、胚胎着床前基因检测 (PGT) 和直接面向消费者的基因检测的普及。

政府对产前检测和新生儿基因筛检的倡议和支持预计将在不久的将来推动产前和新生儿基因检测市场的扩张。这些措施包括各级政府机构为解决具体问题或促进人民福祉而采取的具体行动、计划和政策。透过倡导和支持产前和新生儿基因检测计划，政府帮助识别胎儿在怀孕期间或出生后不久的遗传异常和状况。 2022 年 6 月就是一个例子，当时澳洲政府每年向新南威尔斯 (NSW)新生儿筛检计画拨款 130 万美元。此资金促进了严重复合型免疫力缺乏（SCID）和脊髓性肌肉萎缩症（SMA）的免费检测。它将为该州的每个新生儿提供基因筛检，有可能挽救每年出生的 10 万名婴儿中 13 名患有这些遗传疾病的婴儿的生命。因此，政府加强产前和新生儿基因筛检的努力正在推动各自检测市场的成长。

遗传疾病的增加预计将推动未来产前和新生儿基因检测市场的激增。遗传性疾病是指由个体 DNA 或遗传物质异常或突变所引起的健康状况。产前和新生儿基因检测在早期（通常在症状出现之前）识别这些疾病方面发挥着重要作用。这种早期检测使医疗保健提供者能够及时采取干预措施和治疗策略，从而避免或减少此类情况的影响。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球产前和新生儿基因检测市场，按产品类型、性能和预测细分，2018-2023、2023-2028、2033
  • 消耗品
  • 装置
  • 全球产前和新生儿基因检测市场，按筛检、绩效和预测细分，2018-2023、2023-2028、2033
  • 非侵入性产前检测
  • 慢性绒毛取样
  • 羊膜穿刺术
  • 母体血清筛检
  • 其他筛检
  • 全球产前和新生儿基因检测市场，按疾病、表现和预测细分，2018-2023、2023-2028、2033
  • 唐氏症
  • 苯酮尿症
  • 囊肿纤维化
  • 镰状细胞性贫血
  • 全球产前和新生儿基因检测市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 医院
  • 产科和专科诊所
  • 诊断中心

第 7 章 区域与国家分析

  • 全球产前和新生儿基因检测市场，按地区、表现和预测，2018-2023、2023-2028、2033
  • 全球产前和新生儿基因检测市场，按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 产前及新生儿基因检测市场竞争形势
  • 产前及新生儿基因检测市场公司概况
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories

第31章 其他大型创新公司

  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Quest Diagnostic Incorporated
  • Agilent Technologies Inc.
  • Grifols SA
  • Terumo Corporation
  • Illumina Inc.
  • PerkinElmer Genomics
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Werfen SA
  • DiaSorin SpA
  • Nova Biomedical

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13371

Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.

The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $5.87 billion in 2023 to $6.68 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth observed during the historic period can be attributed to several factors, including advancements in improved non-invasive prenatal testing methods, a rise in maternal age, support from governmental initiatives and healthcare policies, and increased patient demand for early detection of potential health issues during pregnancy.

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to the expansion of genetic test panels, a growing awareness of maternal health, adherence to prenatal and newborn screening guidelines, an increased focus on rare diseases, and considerations related to ethics and regulations. Major trends expected during the forecast period include the widespread adoption of non-invasive prenatal testing (NIPT), the utilization of genome sequencing (WGS) and whole exome sequencing, the integration of artificial intelligence (AI) in genetic testing processes, the practice of preimplantation genetic testing (PGT), and the popularity of direct-to-consumer genetic testing.

Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.

The mounting occurrence of genetic disorders is expected to drive the proliferation of the prenatal and newborn genetic testing market in the future. Genetic disorders denote medical conditions arising from abnormalities or mutations within an individual's DNA or genetic material. Prenatal and newborn genetic testing play a crucial role in identifying these disorders at an early stage, often before any symptoms become evident. This early identification enables healthcare providers to initiate timely interventions and treatment strategies, thus potentially averting or mitigating the impact of such conditions. For instance, statistics from 2021 from the Centers for Disease Control and Prevention (CDC) reveal that congenital disabilities affect approximately 3% of babies born in the United States annually, making them the leading cause of infant deaths, accounting for 20% of all infant mortalities. Hence, the rising incidence of genetic disorders propels the prenatal and newborn genetic testing market.

The ethical and legal ramifications present a potential impediment to the growth of the market in the forecast period. These implications refer to the consequences, considerations, and obligations linked to actions or decisions that encompass both ethical and legal facets. Within the prenatal and newborn genetic testing markets, ethical and legal concerns serve as constraints, impacting the accuracy and reliability of test outcomes while raising privacy and autonomy issues. For instance, as of July 2022, reports from the American Civil Liberties Union have highlighted authorities' attempts to access blood samples from newborns for criminal investigations. This exploitation of vast genetic data for law enforcement jeopardizes public trust in this vital health initiative and threatens genetic privacy rights by using this information to potentially link a child's relative to a crime. Consequently, ethical and legal implications related to genetic testing impede the prenatal and newborn genetic testing markets.

Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.

In July 2021, Genetic Technologies Limited, an Australia-based biotechnology research firm, completed the acquisition of EasyDNA for $4 million. This strategic move by Genetic Technologies Limited is designed to broaden its geographic presence and harness the specialized skills and capabilities of EasyDNA. The objective behind this acquisition is to facilitate the development, production, and increased accessibility of carrier testing and non-invasive prenatal tests (NIPT), thereby catering to previously unaddressed market requirements. EasyDNA, a Malta-based company, specializes in DNA testing services, particularly in pre-conception and prenatal testing.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech plc, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

North America was the largest region in the prenatal and newborn genetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal And Newborn Genetic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal and newborn genetic testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Consumables; Instruments
  • 2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
  • 3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
  • 4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
  • Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Prenatal And Newborn Genetic Testing Market Size and Growth

  • 5.1. Global Prenatal And Newborn Genetic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal And Newborn Genetic Testing Market Segmentation

  • 6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • 6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Non-Invasive Prenatal Testing
  • Chronic Villus Sampling
  • Amniocentesis
  • Maternal Serum Screening
  • Other Screenings
  • 6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Down Syndrome
  • Phenylketonuria
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • 6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Maternity And Specialty Clinics
  • Diagnostic Centers

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

  • 8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal And Newborn Genetic Testing Market

  • 9.1. China Prenatal And Newborn Genetic Testing Market Overview
  • 9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal And Newborn Genetic Testing Market

  • 10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal And Newborn Genetic Testing Market

  • 11.1. Japan Prenatal And Newborn Genetic Testing Market Overview
  • 11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal And Newborn Genetic Testing Market

  • 12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal And Newborn Genetic Testing Market

  • 13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal And Newborn Genetic Testing Market

  • 14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview
  • 14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal And Newborn Genetic Testing Market

  • 15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview
  • 15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal And Newborn Genetic Testing Market

  • 16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal And Newborn Genetic Testing Market

  • 17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal And Newborn Genetic Testing Market

  • 18.5. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal And Newborn Genetic Testing Market

  • 19.9. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal And Newborn Genetic Testing Market

  • 20.13. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

  • 21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview
  • 21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal And Newborn Genetic Testing Market

  • 22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal And Newborn Genetic Testing Market

  • 23.1. North America Prenatal And Newborn Genetic Testing Market Overview
  • 23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal And Newborn Genetic Testing Market

  • 24.1. USA Prenatal And Newborn Genetic Testing Market Overview
  • 24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal And Newborn Genetic Testing Market

  • 25.1. Canada Prenatal And Newborn Genetic Testing Market Overview
  • 25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal And Newborn Genetic Testing Market

  • 26.1. South America Prenatal And Newborn Genetic Testing Market Overview
  • 26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal And Newborn Genetic Testing Market

  • 27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal And Newborn Genetic Testing Market

  • 28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview
  • 28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal And Newborn Genetic Testing Market

  • 29.1. Africa Prenatal And Newborn Genetic Testing Market Overview
  • 29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape
  • 30.2. Prenatal And Newborn Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi S.A.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthineers AG
  • 31.3. Becton, Dickinson and Company
  • 31.4. Quest Diagnostic Incorporated
  • 31.5. Agilent Technologies Inc.
  • 31.6. Grifols S.A.
  • 31.7. Terumo Corporation
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Genomics
  • 31.10. Quidel Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen NV
  • 31.13. Werfen S.A.
  • 31.14. DiaSorin S.p.A
  • 31.15. Nova Biomedical

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking

33. Global Prenatal And Newborn Genetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market Future Outlook and Potential Analysis

  • 35.1 Prenatal And Newborn Genetic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Prenatal And Newborn Genetic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Prenatal And Newborn Genetic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer